In a phase 3 study population of patients with PPD (N = 90), LPCN 1154 did not demonstrate a statistically significant reduction from baseline in the HAM-D17 total score at 60 hours (primary endpoint) compared to placebo. The primary endpoint was not met In a post hoc analysis of participants (n = 54) with a … Read more
– PGN-EDODM1 was generally well tolerated with all adverse events being mild or moderate and no serious adverse events reported – – Dissociation correction observed with PGN-EDODM1 (n=6) versus 6.8% with placebo (n=2); 7.3%; With the exception of one outpatient, the treatment group showed a mean improvement of 22.9% (n = 5). – A significant … Read more
Share on PinterestA major study suggests that stroke care supported by AI can lead to better patient outcomes. Image credit: TEK IMAGE/SCIENCE PHOTO LIBRARY/Getty Images A new study suggests that a stroke clinical decision support system (CDSS), which uses artificial intelligence (AI)-assisted imaging, can help significantly reduce the risk of vascular events. The researchers suggest … Read more
The researchers found that reducing or increasing daily exposure to sweetened foods over six months did not change how much the adults liked sweets or how much they consumed. This finding challenges the central assumption behind dietary counseling that targeting sweetness itself can alter cravings, eating behaviors, and health outcomes. Sweets and daily food … Read more
cEasy, intuitive and delivering results in minutes, rapid health and wellness tests are popping up on pharmacy shelves across Australia. There are blood skin tests for vitamin D and iron levels, urine tests for perimenopause and menopause, and several health kits that cover urinary tract infections and a cocktail of metrics like glucose, ketones, and … Read more